Crossmark

The additive value of fractionated 177Lu-PSMA-617 administration in treating prostate cancer

Published Online: 2024-11-05

Authors

Zheng, Xiaobei

Cui, Bin

Hou, Wenli

Zhao, Zhongqi

He, Shuhua

Li, Xiao

Xue, Shuai

Luo, Xiu

Ma, Li

Zhang, Lan
License Information

Text and Data Mining valid from 2024-11-05

Version of Record valid from 2024-11-05
More Information

Article History

Received: 21 May 2024

Accepted: 16 October 2024

First Online: 5 November 2024

Document is current